Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jan 13;88(1):120-4.
doi: 10.1038/sj.bjc.6600678.

NF-kappaB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase

Affiliations

NF-kappaB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase

M De Ridder et al. Br J Cancer. .

Abstract

Hypoxic EMT-6 tumour cells displayed a high level of inducible nitric oxide synthase (iNOS) and an increased radiosensitivity after a 16 h exposure to lipopolysaccharide, a known activator of nuclear factor-kappaB (NF-kappaB). Both iNOS activation and radioresponse were impaired by the NF-kappaB inhibitors phenylarsine oxide and lactacystin. Contrasting to other studies, our data show that inhibition of NF-kappaB may impair the radioresponse of tumour cells through downregulation of iNOS.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of lactacystin and PAO on nuclear NF-κB expression and binding activity in hypoxic EMT-6 cells. (A) Cultures were exposed to 0.1 μg ml−1LPS in 1% oxygen for 0–90 min and afterwards analysed for the binding activity of NF-κB in nuclear extracts by EMSA. (B) An analysis of the NF-κB composition was performed using anti-p65 and anti-p50 antibodies. The specificity of NF-κB binding was confirmed by inclusion of unlabelled (cold) NF-κB consensus and its mutant in the binding reactions. (C, D) The effect of a 3 h pretreatment with lactacystin (LC) and a 10 min pretreatment with PAO on the expression and binding activity of NF-κB was evaluated after a 60 min exposure to 0.1 μg ml−1 LPS. The figure is representative of three independent experiments.
Figure 2
Figure 2
Effect of lactacystin and PAO on iNOS expression in hypoxic EMT-6 cells. (A) EMT-6 cultures were exposed to 0.001–0.1 μg ml−1 LPS in 1% oxygen and afterwards analysed for the expression of iNOS by Western blotting. The last lane illustrates the iNOS induction by LPS in 21% oxygen. (B, C) iNOS expression after a 3 h pretreatment with lactacystin (LC) and a 10 min pretreatment with PAO followed by a 16 h exposure to 0.1 μg ml−1 LPS in 1% oxygen. The figure is representative of four independent experiments.
Figure 3
Figure 3
Effect of lactacystin and PAO on nitrite production by EMT-6 cells. (A) EMT-6 cultures were exposed to 0.0001–0.1 μg ml−1 LPS for 16 h in 1% oxygen and afterwards analysed for the accumulation of nitrite, with or without 3 mM aminoguanidine. (B) Nitrite production after a 3 h pretreatment with lactacystin (LC) and a 10 min pretreatment with PAO followed by exposure to 0.1 μg ml−1 LPS in 1% oxygen.
Figure 4
Figure 4
Radioresponse of hypoxic EMT-6 cells after exposure to different concentrations of LPS only (A) and pretreated with NF-κB inhibitors followed by LPS treatment (B). (A) Cells were exposed for 16 h to LPS at 0.001 μg ml−1 (▪), 0.01 μg ml−1 (▴) and 0.1 μg ml−1 (•) in 1% oxygen prior to radiation. The survival curve for nontreated cells (○) and treated with 0.1 μg ml−1 LPS in 21% oxygen (▾) are plotted for reference. (B) Cells were pretreated for 3 h with 40 μM lactacystin (□) for 10 min with 4 mM PAO (▵) or not pretreated (•) prior to exposure to 0.1 μg ml−1 LPS in 1% oxygen. The survival curve for cells treated with 0.1 μg ml−1 LPS and 3 mM aminoguanidine is plotted for reference (⧫).

Similar articles

Cited by

References

    1. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC (1998) Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 58: ;334–341 - PubMed
    1. Bonizzi G, Piette J, Schoonbroodt S, Greimers R, Havard L, Merville MP, Bours V (1999) Reactive oxygen intermediate-dependent NF-κB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity. Mol Cell Biol 19: 1950–1960 - PMC - PubMed
    1. Bradbury CM, Markovina S, Wei SJ, Rene LM, Zoberi I, Horikoshi N, Gius D (2001) Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase. Cancer Res 61: 7689–7696 - PubMed
    1. Dachs GU, Stratford IJ (1996) The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. Br J Cancer 74(Suppl XXVII): S126–S132 - PMC - PubMed
    1. Elliott PJ, Ross JS (2001) The proteasome: a new target for novel drug therapies. Am J Clin Pathol 116: 637–646 - PubMed

Publication types

MeSH terms